The CLIA Waived Drug Test Cup is a preliminary screening test for the presence of drugs. The CLIA Waived Drug Test Cup is a qualitative, immunoassay urine-based, rapid test that incorporates collection of a urine specimen and the testing of multiple drugs simultaneously. For a quantitative result or to confirm a presumptive positive screen, a second, alternative chemical method should be performed on the same urine sample. Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS) or Gas Chromatography/Mass Spectrometry (GC/MS) are the preferred confirmation methods.

Drug Concentrations

The ‘Cutoff Level’ is the concentration level established as a break-point or threshold for labeling a result positive or negative (e.g. 50 ng/mL THC or 150 ng/mL COC). The concentration of a drug is expressed in nanograms (ng) per milliliters (mL) or ng/mL. One nanogram is equal to one billionth of a gram and 1mL is equal to about 1/30 of a fluid ounce.

AMPAmphetamine500 ng/ml or 1000 ng/ml
BARBarbiturates300 ng/ml
BUPBuprenorphine10 ng/ml
BZOBenzodiazepines300 ng/ml
COCCocaine150 ng/ml or 300 ng/ml
COTCotinine200 ng/ml
EDDPMethadone Metabolite300 ng/ml
EtGEthyl Glucuronide300 ng/ml
FYLFentanyl10 ng/ml
K2/SpiceSynthetic Marijuana20 ng/ml
KETKetamine200 ng/ml
METMethamphetamine500 ng/ml or 1000 ng/ml
MDMAEcstasy500 ng/ml
MTDMethadone300 ng/ml
OPIOpiates300 ng/ml or 2000 ng/ml
OXYOxycodone100 ng/ml
PCPPhencyclidine25 ng/mL
THCMarijuana50 ng/ml
TCATricyclic antidepressants1,000 ng/ml
TMLTramadol100 ng/ml
PPXPropoxyphene300 ng/ml